R-L3

(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

(3R)-5-(2-Fluorophényl)-3-(1H-indol-3-ylméthyl)-1-méthyl-1,3-dihydro-2H-1,4-benzodiazépin-2-one

(3R)-5-(2-Fluorphenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on

2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-, (3R)-

R-L3

(3R)-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-3H-1,4-benzodiazepin-2-one

(R)-3-((1H-indol-3-yl)methyl)-5-(2-fluorophenyl)-1-methyl-1H-benzo[e][1,4]diazepin-2(3H)-one

103342-82-1

5-(2-Fluorophenyl)-1,3-dihydro-3-(1 <em>H</em>-indol-3-ylmethyl)-1-methyl-2<em>H</em>-1,4-benzodiazepin- 2-one

5-(2-Fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one

CCK antagonistmissing

CCKN_RAT

Cholecystokinin

D7RA28_PIG

GABA type A receptor-associated protein

GABA(A) receptor-associated protein

L-364,373

R-L364,373